Literature DB >> 7561916

Raised plasma arginine vasopressin concentrations during cluster headache attacks.

R Franceschini1, M Leandri, A Cataldi, E Bruno, G Corsini, E Rolandi, T Barreca.   

Abstract

To obtain data about peripheral concentrations of arginine vasopressin in head pain syndromes, the plasma arginine vasopressin secretory pattern in 12 adult male patients with cluster headache was evaluated. Blood samples for plasma arginine vasopressin and osmolality determinations were collected before, and at 15, 30, 45, 60, 90, and 120 minutes during a cluster attack. Blood pressure was also monitored. The same sampling was repeated during an asymptomatic period. During cluster attacks, the mean values of plasma arginine vasopressin before an attack (2.3 (0.1) ng/l) significantly increased, reaching their peak at 45 minutes (4.8 (0.5) ng/l; P < 0.01 v baseline). No significant variations were found in mean arterial pressure and plasma osmolality. These data suggested involvement of neurotransmitter mechanisms regulating arginine vasopressin secretion and a possible role of arginine vasopressin in vasomotor phenomena accompanying cluster attacks.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561916      PMCID: PMC486073          DOI: 10.1136/jnnp.59.4.381

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha.

Authors:  S S Nussey; J Hawthorn; S R Page; V T Ang; J S Jenkins
Journal:  Clin Endocrinol (Oxf)       Date:  1988-03       Impact factor: 3.478

2.  Noxious somatic stimuli excite neurosecretory vasopressin cells via A1 cell group.

Authors:  T A Day; J R Sibbald
Journal:  Am J Physiol       Date:  1990-06

3.  Vasopressin release due to manual restraint in the rat: role of body compression and comparison with other stressful stimuli.

Authors:  M K Husain; W M Manger; T W Rock; R J Weiss; A G Frantz
Journal:  Endocrinology       Date:  1979-03       Impact factor: 4.736

Review 4.  Vasopressin in the regulation of body functions.

Authors:  E Mohr; D Richter
Journal:  J Hypertens       Date:  1994-04       Impact factor: 4.844

Review 5.  The regulation of vasopressin function in health and disease.

Authors:  G L Robertson
Journal:  Recent Prog Horm Res       Date:  1976

6.  Evidence for dopamine as an inhibitor of vasoprotein release in man.

Authors:  S L Lightman; M Forsling
Journal:  Clin Endocrinol (Oxf)       Date:  1980-01       Impact factor: 3.478

7.  Plasma vasopressin levels in induced migraine attacks.

Authors:  R C Peatfield; K K Hampton; P J Grant
Journal:  Cephalalgia       Date:  1988-03       Impact factor: 6.292

8.  Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus.

Authors:  E T Cunningham; P E Sawchenko
Journal:  J Comp Neurol       Date:  1988-08-01       Impact factor: 3.215

9.  The influence of CGP 28392, a 1,4-dihydropyridine, on human platelet calcium and cyclic AMP metabolism.

Authors:  T J Resink; P Erne; F R Bühler
Journal:  Eur J Pharmacol       Date:  1985-07-31       Impact factor: 4.432

10.  Inhibition of vasopressin secretion during migraine.

Authors:  C J Poole; S L Lightman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

View more
  1 in total

Review 1.  Emerging relevance of circadian rhythms in headaches and neuropathic pain.

Authors:  Mark J Burish; Zheng Chen; Seung-Hee Yoo
Journal:  Acta Physiol (Oxf)       Date:  2018-07-25       Impact factor: 6.311

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.